Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Astrazeneca plc symbols : Fgen save search
Europe Idiopathic Pulmonary Fibrosis Market to Grow by 6.1% Annually Through 2027
Published: 2022-08-10 (Crawled : 13:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 4.53%
H: 0.0%
C: -1.15%
GLPG | News | $29.45 1.31% 1.36% 110K
|
Health Technology
|
| O: 2.06%
H: 0.7%
C: 0.46%
FGEN | $1.07 -6.14% -6.54% 1.3M
|
Health Technology
|
| O: 3.54%
H: 0.0%
C: -1.03%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: 1.78%
H: 0.03%
C: -1.13%
europe fibrosis market
Idiopathic Pulmonary Fibrosis Market Size to hit USD 5326.8 Million in 2028 | Growing at 7.1 % CAGR, Says Brandessence Market Research
Published: 2022-06-03 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: -0.4%
H: 4.05%
C: -1.35%
BMY | $48.99 -0.31% 0.41% 7.1M
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
GLPG | News | $29.45 1.31% 1.36% 110K
|
Health Technology
|
| O: 0.29%
H: 2.68%
C: 2.39%
FGEN | $1.07 -6.14% -6.54% 1.3M
|
Health Technology
|
| O: 1.57%
H: 2.99%
C: 2.99%
BIIB | $193.18 -0.48% -0.48% 1.2M
|
Health Technology
|
| O: 1.16%
H: 3.3%
C: 1.27%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
fibrosis research growing market
Idiopathic Pulmonary Fibrosis Market to Reach $6.16 Bn, Globally, by 2030 at 7.0% CAGR: Allied Market Research
Published: 2022-02-07 (Crawled : 13:30) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 2.69%
H: 0.5%
C: -1.76%
BMY | $48.99 -0.31% 0.41% 7.1M
|
Health Technology
|
| O: 3.7%
H: 1.64%
C: 1.24%
GLPG | News | $29.45 1.31% 1.36% 110K
|
Health Technology
|
| O: 2.54%
H: 1.58%
C: 0.1%
FGEN | $1.07 -6.14% -6.54% 1.3M
|
Health Technology
|
| O: -1.09%
H: 9.3%
C: 8.82%
BIIB | $193.18 -0.48% -0.48% 1.2M
|
Health Technology
|
| O: 2.54%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: -0.14%
H: 1.01%
C: 0.87%
fibrosis research
FibroGen Provides Regulatory Update on Roxadustat
Published: 2021-03-01 (Crawled : 21:03) - globenewswire.com
FGEN | $1.07 -6.14% -6.54% 1.3M
|
Health Technology
|
| O: -24.8%
H: 3.74%
C: 0.18%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: 0.64%
H: 0.06%
C: -1.38%
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.